Darolutamide | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Darolutamide
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Darolutamide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 4 USDMF, 1 EU WC, 1 KDMF, 2 NDC API, 6 Listed Suppliers, $ API Reference Price

9 API Suppliers
4 USDMF
1 EU WC
1 KDMF
2 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

55 Drugs in Development

55 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 1 FDA Orange Book, 1 Europe, 1 Canada, 2 Australia, 1 South Africa

6 FDF Dossiers
1 FDA Orange Book
1 Europe
1 Canada
2 Australia
1 South Africa

DIGITAL CONTENT

82 NEWS #PharmaBuzz

82 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices, 2 Annual Reports

1 US Medicaid Prescriptions
1 Finished Drug Prices
2 Annual Reports

MARKET PLACE

2 FDF Dossiers

2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 2 US Exclusivities

8 US Patents
2 US Exclusivities

$ API Ref.Price (USD/KG) : 14,414 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8BAYER HEALTHCARE

filter Patent Number Reset all filters

8 All

01 18975254

02 19657003

03 110010530

04 110383853

05 110711013

06 110835515

07 111046713

08 111168058

filter API Patent Reset all filters

8 All

01 7Y

02 1Blank

filter FDF Patent Reset all filters

8 All

01 5Y

02 3Blank

filter Expiration Date Reset all filters

8 All

01 32030-10-27

02 12033-03-25

03 32036-01-28

04 12038-02-27

Product Main Page

01

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-25

DAROLUTAMIDE

US Patent Number : 8975254

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-27

DAROLUTAMIDE

US Patent Number : 9657003

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10835515

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10010530

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-27

DAROLUTAMIDE

US Patent Number : 11046713

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10383853

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-02-27

DAROLUTAMIDE

US Patent Number : 11168058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-02-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

BAYER HEALTHCARE

BioAsia

Not Confirmed

BAYER HEALTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-27

DAROLUTAMIDE

US Patent Number : 10711013

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!